A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)

BACKGROUND: Individuals who receive allogeneic hematopoietic cell transplant (allo-HCT) are immunocompromised and at high risk of pneumococcal infections, especially in the months following transplant. This study evaluated the safety and immunogenicity of V114 (VAXNEUVANCE; Merck, Sharp & Dohme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilck, Marissa, Cornely, Oliver A, Cordonnier, Catherine, Velez, Juan Diego, Ljungman, Per, Maertens, Johan, Selleslag, Dominik, Mullane, Kathleen M, Nabhan, Samir, Chen, Qiuxu, Dagan, Ron, Richmond, Peter, Daus, Caroline, Geddie, Kateasha, Tamms, Gretchen, Sterling, Tina, Patel, Shrita M, Shekar, Tulin, Musey, Luwy, Buchwald, Ulrike K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573722/
https://www.ncbi.nlm.nih.gov/pubmed/37338158
http://dx.doi.org/10.1093/cid/ciad349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573722/
https://www.ncbi.nlm.nih.gov/pubmed/37338158
http://dx.doi.org/10.1093/cid/ciad349

Ejemplares similares